Document is current
Any future updates will be listed below
-
Authors
Reason, Tim
Benbow, Emma
Langham, Julia https://orcid.org/0000-0003-1046-7598
Gimblett, Andy
Klijn, Sven L. https://orcid.org/0000-0002-1556-8382
Malcolm, Bill
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Accepted: 1 February 2024
First Online: 10 February 2024
Declarations
:
: This study was supported by Bristol Myers Squibb.
: Tim Reason, Emma Benbow, Julia Langham, and Andy Gimblett are consultants at Estima Scientific and have worked on behalf of Bill Malcolm and Sven L. Klijn, who are employees and shareholders of Bristol Myers Squibb.
: All data generated or analysed during this study are included in this published article (and its supplementary information files).
: Not applicable.
: Not applicable.
: Not applicable.
: Examples for using R’s ‘multinma’ package were provided to GPT-4 for context for the binary outcome (Beta-blockers example) and time-to-event outcomes (Parkinson’s disease example). Vignettes, including these examples, are provided here: .
: T.R.: idea conceptualisation, development of approach and editorial input. E.B.: development of approach, critical appraisal of SLR and NMA and drafting versions of the paper. J.L.: critical appraisal of SLR and NMA and editorial input. A.G.: Python and API technical input. S.L.K.: technical input and editorial input. W.M.: technical input and editorial input.
